These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 25843893

  • 21. Cytokine expression in peripheral blood mononuclear cells of dogs with mitral valve disease.
    Mavropoulou A, Guazzetti S, Borghetti P, De Angelis E, Quintavalla C.
    Vet J; 2016 May; 211():45-51. PubMed ID: 27033593
    [Abstract] [Full Text] [Related]

  • 22. Serotonin transmembrane transporter is down-regulated in late-stage canine degenerative mitral valve disease.
    Scruggs SM, Disatian S, Orton EC.
    J Vet Cardiol; 2010 Dec; 12(3):163-9. PubMed ID: 21036114
    [Abstract] [Full Text] [Related]

  • 23. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs.
    Lee CM, Jeong DM, Kang MH, Kim SG, Han JI, Park HM.
    Am J Vet Res; 2017 Apr; 78(4):440-446. PubMed ID: 28345991
    [Abstract] [Full Text] [Related]

  • 24. Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves.
    Disatian S, Lacerda C, Orton EC.
    J Heart Valve Dis; 2010 Jan; 19(1):71-8. PubMed ID: 20329492
    [Abstract] [Full Text] [Related]

  • 25. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
    Reimann MJ, Ljungvall I, Hillström A, Møller JE, Hagman R, Falk T, Höglund K, Häggström J, Olsen LH.
    Vet J; 2016 Mar; 209():113-8. PubMed ID: 26831162
    [Abstract] [Full Text] [Related]

  • 26. Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease.
    Reimann MJ, Cremer S, Christiansen L, Ibragimov E, Gao F, Cirera S, Fredholm M, Olsen LH, Karlskov-Mortensen P.
    Mamm Genome; 2024 Mar; 35(1):77-89. PubMed ID: 37938355
    [Abstract] [Full Text] [Related]

  • 27. Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs.
    Rešetar Maslov D, Farkaš V, Rubić I, Kuleš J, Beletić A, Beer Ljubić B, Šmit I, Mrljak V, Torti M.
    Int J Mol Sci; 2023 Apr 12; 24(8):. PubMed ID: 37108311
    [Abstract] [Full Text] [Related]

  • 28. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S, Green D, Christley R, Dukes-McEwan J.
    J Vet Cardiol; 2019 Jun 12; 23():21-31. PubMed ID: 31174726
    [Abstract] [Full Text] [Related]

  • 29. Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs.
    Li Q, Heaney A, Langenfeld-McCoy N, Boler BV, Laflamme DP.
    BMC Vet Res; 2019 Nov 27; 15(1):425. PubMed ID: 31775756
    [Abstract] [Full Text] [Related]

  • 30. Increased expression of 5-HT(2A) and 5-HT(2B) receptors in detrusor muscle after partial bladder outlet obstruction in rats.
    Michishita M, Yano K, Kasahara K, Tomita K, Matsuzaki O.
    Biomed Res; 2015 Nov 27; 36(3):187-94. PubMed ID: 26106048
    [Abstract] [Full Text] [Related]

  • 31. The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart disease.
    Kekewska A, Hübner H, Gmeiner P, Pertz HH.
    J Pharmacol Exp Ther; 2011 Jul 27; 338(1):381-91. PubMed ID: 21518772
    [Abstract] [Full Text] [Related]

  • 32. Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats.
    Ayme-Dietrich E, Marzak H, Lawson R, Mokni W, Wendling O, Combe R, Becker J, El Fertak L, Champy MF, Matz R, Andriantsitohaina R, Doly S, Boutourlinsky K, Maroteaux L, Monassier L.
    J Hypertens; 2015 Nov 27; 33(11):2310-21. PubMed ID: 26259125
    [Abstract] [Full Text] [Related]

  • 33. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    Vet Clin Pathol; 2013 Jun 27; 42(2):196-206. PubMed ID: 23614733
    [Abstract] [Full Text] [Related]

  • 34. Differentially expressed platelet activation-related genes in dogs with stage B2 myxomatous mitral valve disease.
    Zhou Q, Cui X, Zhou H, Guo S, Wu Z, Li L, Zhang J, Feng W, Guo Y, Ma X, Chen Y, Qiu C, Xu M, Deng G.
    BMC Vet Res; 2023 Dec 13; 19(1):271. PubMed ID: 38087280
    [Abstract] [Full Text] [Related]

  • 35. Increased NADPH-diaphorase activity in canine myxomatous mitral valve leaflets.
    Olsen LH, Mortensen K, Martinussen T, Larsson LI, Baandrup U, Pedersen HD.
    J Comp Pathol; 2003 Dec 13; 129(2-3):120-30. PubMed ID: 12921717
    [Abstract] [Full Text] [Related]

  • 36. Genetics of canine myxomatous mitral valve disease.
    O'Brien MJ, Beijerink NJ, Wade CM.
    Anim Genet; 2021 Aug 13; 52(4):409-421. PubMed ID: 34028063
    [Abstract] [Full Text] [Related]

  • 37. Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel.
    Markby GR, Macrae VE, Corcoran BM, Summers KM.
    BMC Vet Res; 2020 Sep 23; 16(1):350. PubMed ID: 32967675
    [Abstract] [Full Text] [Related]

  • 38. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
    Zois NE, Moesgaard SG, Kjelgaard-Hansen M, Rasmussen CE, Falk T, Fossing C, Häggström J, Pedersen HD, Olsen LH.
    Vet J; 2012 Apr 23; 192(1):106-11. PubMed ID: 21696985
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease.
    Hong HJ, Oh YI, Park SM, An JH, Kim TH, Chae HK, Seo KW, Youn HY.
    BMC Vet Res; 2022 Jul 05; 18(1):261. PubMed ID: 35790968
    [Abstract] [Full Text] [Related]

  • 40. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.
    Aupperle H, Disatian S.
    J Vet Cardiol; 2012 Mar 05; 14(1):59-71. PubMed ID: 22364722
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.